TLDR The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.
The study conducted an immunohistochemical analysis of the mTOR and hypoxia signaling pathways in basal cell carcinoma (BCC) and trichoepithelioma (TE) using 45 BCC and 35 TE samples. Both tumor types exhibited significant activation of the mTOR pathway, with BCC showing higher activation levels. Hypoxia-inducible factor 1-alpha (HIF-1α) was upregulated in BCC, indicating a role of hypoxia signaling in its pathogenesis. The findings suggested that while these pathways are active in both BCC and TE, they do not serve as reliable diagnostic tools to distinguish between the two, but they do highlight potential therapeutic targets for BCC.
33 citations,
August 2013 in “Journal of Investigative Dermatology” Human hair follicle stem cells show signs of low oxygen levels, which may be important for hair growth and preventing baldness.
351 citations,
February 2010 in “Nature Cell Biology” Basal cell carcinoma mostly starts from cells in the upper skin layers, not hair follicle stem cells.
[object Object]
106 citations,
March 2014 in “BioEssays” We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.
9 citations,
May 2019 in “Experimental Cell Research” HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.
[object Object] April 2018 in “Journal of Investigative Dermatology” Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.
21 citations,
November 2021 in “Cells” Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.
144 citations,
August 2019 in “Cells” The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.